Key result
Endothelial cell CD36 ablation restores Kir2.1 currents and flow-induced vasodilation in obese mice.
Why the study?
Elevated plasma long chain fatty acids in obesity inhibit Kir2.1 channels contributing to endothelial dysfunction, prompting investigation into whether endothelial cell CD36 mediates this impairment.
Endothelial cell CD36 ablation attenuates obesity-induced endothelial dysfunction by restoring Kir2.1 channel function, highlighting a potential CD36/Kir2.1 therapeutic axis.
No takes yet. Share an insight, caveat, or question.
Kir2.1 loss may drive endothelial dysfunction in obesity; leaves open whether channel activation improves human cardiovascular outcomes.
Johnson et al. (2026) studied Obesity-induced endothelial dysfunction. Endothelial cell CD36 ablation vs. Lean and genotype controls was evaluated on Kir2.1 currents, flow-induced vasodilation, and fatty acid uptake. Endothelial cell CD36 ablation restored Kir2.1 currents and flow-induced vasodilation in obese mice, and attenuated elevated fatty acid uptake compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: